Summary by Futu AI
Pharmaceutical Biotechnology Co., Ltd. (Pharmaceutical Biologics) completed a series of share repurchase activities on 3 April 2024 and disclosed the relevant changes to the Hong Kong Stock Exchange Limited (HKEX). According to the disclosure statement, the company conducted multiple share repurchases through the Hong Kong Stock Exchange between December 7, 2023 and April 3, 2024, totaling 87,177,000 shares, accounting for 2.05199 percent of the issued shares. Of these, 565,000 shares were repurchased on 3 April 2024 at a price of between HKD 14.04 and HKD 14.1 for a total payment of HKD 7,943,880. In addition, a share option was exercised on the same day, adding 359,100 shares to the issue at HKD 2.18 per share, representing a discount of 84.65% from the current closing price of HKD 14.2. Pharma confirms that all payments have been received and that all the prerequisites required by the Listing Rules have been met. As of April 3, 2024, the outstanding shares of Pharmaceutical Biologics were issued in the amount of 4,258,970,569 shares.